David L. Bourdet
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Drug-Induced Hepatotoxicity and Protection 4
- Oncology 11
- Drug Transport and Resistance Mechanisms 9
- Co-authors
- Dhiren R. Thakker (6 shared papers)William R. Proctor (2 shared papers)John B. Pritchard (1 shared paper)Gary M. Pollack (1 shared paper)Kim L. R. Brouwer (2 shared papers)Patrick J. Brassil (2 shared papers)Philip D. Worboys (1 shared paper)Jayaprakasam Bolleddula (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (3 papers)Drug Metabolism and Disposition (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Journal of Medicinal Chemistry (3 papers)Clinical and Translational Science (2 papers)
- Partner nations
- United StatesUnited KingdomUkraine
In The Last Decade
David L. Bourdet
31 papers receiving 926 citations
Peers
Comparison fields: 5 of 96
- Pharmacology 207
- Pharmaceutical Science 84
- Oncology 341
- Pediatrics, Perinatology and Child Health 147
- Hepatology 43
Countries citing papers authored by David L. Bourdet
This map shows the geographic impact of David L. Bourdet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Bourdet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Bourdet more than expected).
Fields of papers citing papers by David L. Bourdet
This network shows the impact of papers produced by David L. Bourdet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Bourdet. The network helps show where David L. Bourdet may publish in the future.
Co-authors
The 25 scholars most cited alongside David L. Bourdet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 118 | |
| 2 | 2018 | 97 | |
| 3 | 2005 | 95 | |
| 4 | 2006 | 85 | |
| 5 | 2014 | 69 | |
| 6 | 2011 | 64 | |
| 7 | 2006 | 50 | |
| 8 | 2021 | 40 | |
| 9 | 2006 | 37 | |
| 10 | 2019 | 35 | |
| 11 | 2017 | 34 | |
| 12 | 2013 | 33 | |
| 13 | 2010 | 28 | |
| 14 | 2015 | 26 | |
| 15 | 2016 | 24 | |
| 16 | 2021 | 22 | |
| 17 | 2012 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2021 | 12 | |
| 20 | 2022 | 12 |
About David L. Bourdet
David L. Bourdet is a scholar working on Pharmacology, Oncology, Hepatology, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 34 papers that have together received 971 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Inhalation and Respiratory Drug Delivery (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Pharmacology (207 citations), Pharmaceutical Science (84 citations), Oncology (341 citations), Pediatrics, Perinatology and Child Health (147 citations) and Hepatology (43 citations). David L. Bourdet has collaborated with scholars based in United States, United Kingdom and Ukraine. Frequent co-authors include Dhiren R. Thakker, William R. Proctor, John B. Pritchard, Gary M. Pollack, Kim L. R. Brouwer, Patrick J. Brassil, Philip D. Worboys, Jayaprakasam Bolleddula, James P. Driscoll and Pamela R. Tsuruda. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Journal of Medicinal Chemistry and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.